- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVO
Recent news which mentions NVO
Tickers
NVO
From Motley Fool
Why Hims & Hers Stock Rebounded on Wednesday
February 26, 2025
From Motley Fool
6 Stocks to Buy as European Markets Soar
February 26, 2025
From Benzinga
Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision
February 26, 2025
From Benzinga
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
February 24, 2025
From Motley Fool
From Benzinga
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
February 23, 2025
From Motley Fool
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
February 21, 2025
From Benzinga
Why Novo Nordisk Stock Popped on Friday
February 21, 2025
From Motley Fool
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
February 19, 2025
Tickers
NVO
From Benzinga
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
February 19, 2025
From Motley Fool
From Benzinga
Novo Nordisk Sues Singapore-Based KBP Biosciences Over Alleged Data Misrepresentation In $1.3 Billion Hypertension Drug Deal, Seeks Damages
February 19, 2025
From Benzinga
Digging Into What Hershey and Eli Lilly Told Investors
February 19, 2025
From Motley Fool
3 Hot Stocks That Have Already Doubled in 2025
February 18, 2025
From Motley Fool
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
February 18, 2025
From Benzinga
2 Important Insights From Novo Nordisk's Earnings Call
February 16, 2025
Tickers
NVO
From Motley Fool
Tickers
NVO
From Motley Fool
From Benzinga
From Motley Fool
Is Novo Nordisk Stock a Buy Now?
February 08, 2025
From Motley Fool
Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data
February 07, 2025
From Benzinga
Mark Cuban Calls Out Elon Musk's Growing Influence Under Trump: 'On A Mission To Make Himself...Above And Beyond The President Of The United States'
February 07, 2025
From Benzinga
Denmark Could Ban Or Push Ozempic, Wegovy And Shipping Prices Through The Roof If Trump Escalates Over Greenland
February 06, 2025
From Benzinga
3 Cheap Growth Stocks You Can Buy for Less Than $100
February 06, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.